Works by Raffaelli, Bianca
Results: 55
Sex-related differences in frequency and perception of stressful life events during adolescence.
- Published in:
- Journal of Public Health: From Theory to Practice (2198-1833), 2016, v. 24, n. 5, p. 365, doi. 10.1007/s10389-016-0731-x
- By:
- Publication type:
- Article
Predictive utility of the NEO-FFI for later substance experiences among 16-year-old adolescents.
- Published in:
- Journal of Public Health: From Theory to Practice (2198-1833), 2016, v. 24, n. 6, p. 489, doi. 10.1007/s10389-016-0747-2
- By:
- Publication type:
- Article
Resumption of migraine preventive treatment with CGRP(-receptor) antibodies after a 3-month drug holiday: a real-world experience.
- Published in:
- Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-022-01417-9
- By:
- Publication type:
- Article
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study.
- Published in:
- Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-022-01408-w
- By:
- Publication type:
- Article
Deterioration of headache impact and health-related quality of life in migraine patients after cessation of preventive treatment with CGRP(−receptor) antibodies.
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01368-7
- By:
- Publication type:
- Article
Primary headaches during the COVID-19 lockdown in Germany: analysis of data from 2325 patients using an electronic headache diary.
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01273-z
- By:
- Publication type:
- Article
Changes in Health-Related Quality of Life in Patients with Therapy-Resistant Migraine during Treatment with Erenumab in an Ambulatory Care Setting.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 17, p. 5619, doi. 10.3390/jcm12175619
- By:
- Publication type:
- Article
Migraine and Hormonal Contraception in Gynecological Outpatient Care—Cross-Sectional Study among Practicing Gynecologists in Germany.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 4, p. 1434, doi. 10.3390/jcm12041434
- By:
- Publication type:
- Article
Outcomes, unmet needs, and challenges in the management of patients who withdraw from anti-CGRP monoclonal antibodies: A prospective cohort study.
- Published in:
- Cephalalgia, 2024, v. 44, n. 11, p. 1, doi. 10.1177/03331024241273968
- By:
- Publication type:
- Article
Efficacy of eptinezumab in non-responders to subcutaneous monoclonal antibodies against CGRP and the CGRP receptor: A retrospective cohort study.
- Published in:
- Cephalalgia, 2024, v. 44, n. 10, p. 1, doi. 10.1177/03331024241288875
- By:
- Publication type:
- Article
Activation of ATP-sensitive potassium channels triggers migraine attacks independent of calcitonin gene-related peptide receptors: a randomized placebo-controlled trial.
- Published in:
- Cephalalgia, 2024, v. 44, n. 1, p. 1, doi. 10.1177/03331024231222916
- By:
- Publication type:
- Article
Open-label trials for CGRP-targeted drugs in migraine prevention: A narrative review.
- Published in:
- Cephalalgia, 2023, v. 43, n. 2, p. 1, doi. 10.1177/03331024221137091
- By:
- Publication type:
- Article
Visual snow syndrome is probably not mediated by CGRP: A case series.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Effect of antibody switch in non-responders to a CGRP receptor antibody treatment in migraine: A multi-center retrospective cohort study.
- Published in:
- Cephalalgia, 2022, v. 42, n. 4/5, p. 291, doi. 10.1177/03331024211048765
- By:
- Publication type:
- Article
Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort study.
- Published in:
- Cephalalgia, 2022, v. 42, n. 4/5, p. 326, doi. 10.1177/03331024211046617
- By:
- Publication type:
- Article
Effect of calcitonin gene-related peptide (-receptor) antibodies in chronic cluster headache: Results from a retrospective case series support individual treatment attempts.
- Published in:
- Cephalalgia, 2020, v. 40, n. 14, p. 1574, doi. 10.1177/0333102420949866
- By:
- Publication type:
- Article
Near‐death experiences are associated with rapid eye movement (REM) sleep intrusions in migraine patients, independent of migraine aura.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 10, p. 3322, doi. 10.1111/ene.15991
- By:
- Publication type:
- Article
Combining treatments for migraine prophylaxis: the state-of-the-art.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01925-w
- By:
- Publication type:
- Article
Consistency between headache diagnoses and ICHD-3 criteria across different levels of care.
- Published in:
- Journal of Headache & Pain, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s10194-024-01937-6
- By:
- Publication type:
- Article
Migraine in men.
- Published in:
- Journal of Headache & Pain, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s10194-024-01936-7
- By:
- Publication type:
- Article
Correction: PACAP-38 and sex hormones in women with migraine: exploratory analysis of a cross-sectional, matched cohort study.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Patients' and Health Care Workers' Perception of Migraine Images on the Internet: Cross-sectional Survey Study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A Retrospective Real-Life Multicenter Study on Concurrent Oral Preventive Treatments in Patients with Chronic Migraine Treated with OnabotulinumtoxinA.
- Published in:
- CNS Drugs, 2023, v. 37, n. 5, p. 453, doi. 10.1007/s40263-023-01001-y
- By:
- Publication type:
- Article
Indirect Comparison of Topiramate and Monoclonal Antibodies Against CGRP or Its Receptor for the Prophylaxis of Episodic Migraine: A Systematic Review with Meta-Analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
PACAP-38 and sex hormones in women with migraine: exploratory analysis of a cross-sectional, matched cohort study.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01804-4
- By:
- Publication type:
- Article
Therapeutic patterns and migraine disease burden in switchers of CGRP-targeted monoclonal antibodies – insights from the German NeuroTransData registry.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01790-7
- By:
- Publication type:
- Article
Health equity, care access and quality in headache – part 1.
- Published in:
- Journal of Headache & Pain, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01712-7
- By:
- Publication type:
- Article
Health equity, care access and quality in headache – part 2.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01699-7
- By:
- Publication type:
- Article
Impact of a reimbursement policy change on treatment with erenumab in migraine – a real-world experience from Germany.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01682-2
- By:
- Publication type:
- Article
European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3: topiramate.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01671-5
- By:
- Publication type:
- Article
Serum tau protein elevation in migraine: a cross-sectional case–control study.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01663-5
- By:
- Publication type:
- Article
Menstrual migraine is caused by estrogen withdrawal: revisiting the evidence.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01664-4
- By:
- Publication type:
- Article
Clinical evaluation of super-responders vs. non-responders to CGRP(-receptor) monoclonal antibodies: a real-world experience.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01552-x
- By:
- Publication type:
- Article
Health equity, care access and quality in headache – part 1.
- Published in:
- Journal of Headache & Pain, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s10194-024-01712-7
- By:
- Publication type:
- Article
European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure.
- Published in:
- Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-022-01502-z
- By:
- Publication type:
- Article
Long COVID headache.
- Published in:
- Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-022-01450-8
- By:
- Publication type:
- Article
Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA: A Dual-Center Retrospective Observational Study.
- Published in:
- Frontiers in Neurology, 2020, v. 11, p. 1, doi. 10.3389/fneur.2020.00417
- By:
- Publication type:
- Article
Change of CGRP Plasma Concentrations in Migraine after Discontinuation of CGRP-(Receptor) Monoclonal Antibodies.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 1, p. 293, doi. 10.3390/pharmaceutics15010293
- By:
- Publication type:
- Article
A Scoping Review and Meta-Analysis of Anti-CGRP Monoclonal Antibodies: Predicting Response.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 7, p. 934, doi. 10.3390/ph16070934
- By:
- Publication type:
- Article
Perception of typical migraine images on the internet: Comparison between a metropolis and a smaller rural city in Germany.
- Published in:
- PLoS ONE, 2023, v. 18, n. 8, p. 1, doi. 10.1371/journal.pone.0290318
- By:
- Publication type:
- Article
The potential of lasmiditan in migraine.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, p. 1, doi. 10.1177/1756286420967847
- By:
- Publication type:
- Article
The potential of lasmiditan in migraine.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420967847
- By:
- Publication type:
- Article
Advances in pharmacotherapy for the prophylactic treatment of resistant and refractory migraine.
- Published in:
- Expert Opinion on Pharmacotherapy, 2022, v. 23, n. 10, p. 1143, doi. 10.1080/14656566.2022.2088281
- By:
- Publication type:
- Article
The safety and efficacy of the 5-HT 1F receptor agonist lasmiditan in the acute treatment of migraine.
- Published in:
- Expert Opinion on Pharmacotherapy, 2017, v. 18, n. 13, p. 1409, doi. 10.1080/14656566.2017.1361406
- By:
- Publication type:
- Article
Alice in Wonderland Syndrome (AIWS): prevalence and characteristics in adults with migraine.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 8, p. 5146, doi. 10.1007/s00415-024-12471-5
- By:
- Publication type:
- Article
Brain imaging in pregnant women with acute headache.
- Published in:
- Journal of Neurology, 2018, v. 265, n. 8, p. 1836, doi. 10.1007/s00415-018-8924-6
- By:
- Publication type:
- Article
Study Design and Protocol of a Randomized Controlled Trial of the Efficacy of a Smartphone-Based Therapy of Migraine (SMARTGEM).
- Published in:
- Frontiers in Neurology, 2022, p. 1, doi. 10.3389/fneur.2022.912288
- By:
- Publication type:
- Article
Gender Differences in 3-Month Outcomes of Erenumab Treatment—Study on Efficacy and Safety of Treatment With Erenumab in Men.
- Published in:
- Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.774341
- By:
- Publication type:
- Article
Prevalence and characteristics of rapid eye movement sleep behaviour disorder in adults with migraine: a cross‐sectional screening study.
- Published in:
- European Journal of Neurology, 2024, v. 31, n. 10, p. 1, doi. 10.1111/ene.16403
- By:
- Publication type:
- Article
Migräne und Schwangerschaft: Geschlechtsspezifische Aspekte und aktuelles Wissen.
- Published in:
- Der Nervenarzt, 2024, v. 95, n. 4, p. 308, doi. 10.1007/s00115-024-01615-7
- By:
- Publication type:
- Article